.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Merck
Moodys
Medtronic
Express Scripts
Citi
Johnson and Johnson
Cipla
AstraZeneca

Generated: September 22, 2017

DrugPatentWatch Database Preview

NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Naproxen Sodium And Pseudoephedrine Hydrochloride, and what generic Naproxen Sodium And Pseudoephedrine Hydrochloride alternatives are available?

Naproxen Sodium And Pseudoephedrine Hydrochloride is a drug marketed by Perrigo and Dr Reddys Labs Inc and is included in two NDAs.

The generic ingredient in NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.

Summary for Tradename: NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list13
Clinical Trials: see list106,648
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
naproxen sodium; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL076518-001Mar 17, 2004OTCNoNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Inc
NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
naproxen sodium; pseudoephedrine hydrochloride
TABLET, EXTENDED RELEASE;ORAL077381-001Sep 27, 2006OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Dow
Moodys
Farmers Insurance
QuintilesIMS
Fuji
Express Scripts
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot